Introduction
The mannose 6-phosphate/insulin like growth factor II (M6P/IGF II) receptor is a multifunctional receptor binding two structurally unrelated families of ligands Roth, 1988 Tong et al., 1988; Waheed et al., 1988) . The role of the M6P/IGF II receptor in targeting of newly synthesized lysosomal enzymes to lysosomes and endocytosis of lysosomal enzymes has been established (von Figura and Hasilik, 1986) . The lysosomal enzymes bind to the M6P/IGF II receptor via M6P residues in their oligosaccharide chains. IGF II binding to M6P/IGF II receptors has been shown to stimulate DNA-synthesis and cell proliferation, glycogen synthesis and Na+/H+ exchange (Mellas et al., 1986; Nishimoto et al., 1987; Sessions et al., 1987; Hari et al., 1987) .
About 10-20% of the M6P/IGF II receptors are expressed at the cell surface of fibroblasts (Fischer et al., 1980; Braulke et al., 1987) . The surface receptors are in equilibrium with receptors in internal membranes and cycling of the receptors between the cell surface and internal membranes is independent of occupation with M6P-containing ligands (Braulke et al., 1987) or IGF 11 (Oka and Czech, 1986) . The expression of the M6P/IGF II receptors at the cell surface can be stimulated by insulin (Oka et al., 1984; Wardzala et al., 1984) and growth hormone (Bryson and Baxter, 1987) . Insulin induces a redistribution of receptors from internal membranes to the cell surface, which is associated with a decreased phosphorylation of the receptor in the plasma membrane (Covera et al., 1988a) .
In the present study we report on the modulation of the expression of M6P/IGF II receptors at the cell surface by M6P, growth factors and toxins that modify G-proteins.
Results
Stimulation of M6P-binding by M6P, insulin like growth factors, insulin and epidermal growth factor For measuring the M6P binding sites pentamannose 6-phosphate substituted [125I] bovine serum albumin (PMP-BSA) was utilized. This neoglycoprotein binds with high affinity (KD =5 x 10-10 M) to M6P specific receptors (Braulke et al., 1987 (preparation 1932) 190 ± 48 (n = 22) IGF I (10-8 M) 181 ± 35 (n = 10) IGF II (10-8 M) 143 ± 36 (n = 11) rIGF I (10-8 M)
228 ± 87 (n = 27) rIGF II (10-8 M) 156 i 47 (n = 25) EGF (10-8 M) 197 (Table II) . Fructose 1-phosphate and pentamannose phosphate are known to bind to M6P-specific receptors (Kaplan et al., 1977; Waheed et al., 1988 (Table I) . Fibroblasts growth factor (10-8 M) and gran4locyte/macrophage colony stimulating factor (10 ,ug/ ml) had no effect on M6P binding. Treatment with high concentrations of insulin (10-6 M) for 1 h stimulated M6P
binding about 2-fold (Table I) . Lower concentrations of insulin or shorter treatments had little or no effect on M6P binding. Regulation of M6P/IGF 11 receptor expression (Table IV) . Furthermore, the addition of 0.5 mM cycloheximide (which inhibited protein synthesis by more than 95 %) 30 (Gelfand et al., 1987 (Table VIII) . However, the effect of M6P on receptor redistribution was abolished or greatly reduced by pre-incubation with pertussis toxin or cholera toxin (Table VIII) .
Discussion
Control of cell surface receptor expression by cAMP M6P/IGF II receptors recycle constitutively between intracellular membranes and the plasma membrane. Under steady-state conditions 10-20% of the receptors are expressed at the cell surface of human skin fibroblasts (Fischer et al., 1980; Braulke et al., 1987) . Data presented in this study provide evidence that the steady-state distribution of the M6P/IGF 11 receptor is controlled by G-proteindependent mechanisms. The cell surface concentration of M6P/IGF II receptors increases after treatment with cholera toxin and pertussis toxin. Cholera toxin is thought to activate permanently Gs-like proteins and pertussis toxin to inactivate Gi-like proteins through toxin catalysed ADPribosylation of the respective G-proteins (Gilman, 1987) .
Since Gs-like proteins stimulate and G1-like proteins can inhibit adenylyl cyclase, an effect common to both toxins could be the increase of intracellular cAMP. Further evidence for the role of cAMP in the control of M6P/ IGF II receptor distribution comes from preliminary observations (T.Braulke, unpublished results) that forskolin (Rechler and Nissley, 1985; Maly and Liithi, 1986) . More recent analyses with synthetic and recombinant IGF I suggest that M6P/IGF II receptors may have little or no affinity for IGF I (Tally et al., 1987a; Barenton et al., 1987) . Effects of IGF I and IGF II mediated by the same receptor would therefore display a different concentration dependence for the two growth factors. However, similar concentrations of rIGF I and rIGF II (-3 x 10-9 M) induced half maximal receptor redistribution.
Furthermore, the extent of receptor redistribution was significantly different for IGF I and IGF II. This suggests that IGF I and IGF II induce the redistribution via different signal transduction pathways, initiated by binding of IGF I and IGF II to the IGF I and M6P/IGF II receptor, respectively.
Insulin has been shown earlier to induce a redistribution of M6P/IGF II receptors from internal membranes to the cell surface by binding with insulin receptors in rat adipocytes (Oka et al., 1984; Wardzala et al., 1984) and rat H35-hepatoma cells (Covera et al., 1988a) . The insulin receptor-mediated redistribution is associated with a decrease in the overall phosphorylation of the M6P/IGF II receptor (Covera et al., 1988a) . In fibroblasts no significant change in the overall phosphorylation of M6P/IGF II receptors was observed after stimulation with M6P, IGF II, IGF I and EGF (T.Braulke, unpublished results). The high concentrations of insulin that are required to induce redistribution of M6P/ IGF II receptors precludes mediation of the insulin effect in fibroblasts by insulin receptors. It is likely to depend on IGF I receptors, to which insulin binds with low affinity (Rechler and Nissley, 1985 (Rogers and Hammerman, 1988) . In competent BALB/c 3T3 cells primed with EGF, rIGF II stimulates calcium influx via a mechanism sensitive to pertussis toxin (Nishimoto et al., 1987 (lysosomal enzymes, uteroferrin, proliferin) and of IGF II. The biological role of these functions remains to be established. IGF II binding to its receptor has been shown to stimulate glycogen synthesis in rat hepatoma cells , to stimulate proliferation of K-562 cells (Tally et al., 1987b) , to alkalinize cells of the proximal tubular segment from canine kidney by stimulating Na+/H+ exchange across the brush border membrane (Mellas et al., 1986) and to stimulate Ca2 + influx and DNA synthesis in competent BALB/c 3T3 cells primed with EGF (Nishimoto et al., 1987 (preparation 1932) were a kind gift of Dr R.Humbel, University of Zurich. Human IGF I and IGF II produced by recombinant DNA technology were obtained from Dr K.Scheibli, Ciba-Geigy, Basel. EGF, fibroblast growth factor and granulocyte/macrophage colony stimulating factor were obtained from Boehringer-Mannheim. M6P (sodium salt), cholera toxin and pertussis toxin were from Sigma. Fura-2-AM and BABTA -AM were obtained from Molecular Probes (Junction City, OR, USA), insulin and recombinant protein A were from Serva. Pentamannose 6-phosphate was prepared according to Bretthauer et al. (1973) , from Hansenula holstii phosphomannan, which was kindly provided by Dr M.Slodki (United States Department of Agriculture, Northern Regional Research Center, Peoria, IL, USA). PMP-BSA (bovine serum albumin) was prepared and iodinated with Na[ 1251] to a specific activity of 350 mCi/mg with the aid of iodogen (Pierce Chemical Co., Rockford, IL, USA) as described (Braulke et al., 1987) . Protein A was iodinated with iodogen to a specific activity of I mCi/mg.
Cell culture and stimulation protocol Human skin fibroblasts were grown in 35-mm dishes in minimal essential medium (MEM) with 7.5% fetal calf serum to confluency. The cells were washed, incubated at 37°C for 1 h in MEM containing 0.1 % BSA and then stimulated with sugar phosphates or growth factors in the albumin-substituted medium. In experiments with cholera toxin and pertussis toxin, the cells were incubated for 16 h with MEM containing 7.5% fetal calf serum and the toxins and then for I h with albumin-substituted MEM containing the toxins.
Binding and uptake of [1251] PMP-BSA After stimulation at 37°C with the growth factors or M6P, the cells were washed twice for 10 min with 1 ml of ice-cold Hank's buffered salt solution containing 2 mM M6P. The cells were then incubated for 4 h at 0°C with 0.6 ml of MEM containing 7.5% fetal calf serum, 20 mM Hepes, pH 7.2, and 2 ng of [1251]PMP-BSA. Bound [1251]PMP-BSA was displaced by two washes with M6P-supplemented salt solution as above. The cells were solubilized in I N NaOH. Radioactivity was determined in the M6P washes and the solubilized cells and referred to cell protein (Lowry et al., 1951 [Ca2+] . was determined by fluorescence measurements on single cells loaded with fura-2-AM (Grynkiewicz et al., 1985; Neher, 1988) . Cells were incubated for 30 min at room temperature in saline containing 2 ,uM fura-2-AM, followed by incubation at 370C in standard culture medium. Average autofluorescence was measured on non-loaded cells and corrected for. Autofluorescence varied considerably between cells such that absolute values of [Ca2 ] cannot be considered to be accurate. M6P (5 mM) and growth factors (l0-8 M) in MEM, 20 mM Hepes, pH 7.2, containing 0. 1% BSA were applied locally for 20-60 s through a close-by pipette with an opening of 2-3 ym.
For loading with BABTA, cells were incubated for 30 min at 37°C in MEM containing 20 mM Hepes, pH 7.2, 0.1 % BSA and 50 yM BABTA-AM, chased for 30 min in the same medium without BABTA-AM and then stimulated with EGF (10--8 M).
